StockSelector.com
  Research, Select, & Monitor Sunday, April 22, 2018 8:26:47 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
La Jolla Pharmaceutical Compan$30.80$.511.68%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

La Jolla Pharmaceutical Compan has an overall rank of 6163 out of 6819 stocks based on 5 positive rankings and 7 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $100.00 for La Jolla Pharmaceutical Compan using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, La Jolla Pharmaceutical Compan is ranked 40.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, La Jolla Pharmaceutical Compan is ranked 603.
Debt-to-Equity
La Jolla Pharmaceutical Compan rank is 727
90 Day Gain
La Jolla Pharmaceutical Compan rank is 1001
10 Day Gain
La Jolla Pharmaceutical Compan rank is 2483
Negative Rankings
Negative ROE
La Jolla Pharmaceutical Compan rank is 214
Negative ROA
La Jolla Pharmaceutical Compan rank is 216
Price-to-Book
La Jolla Pharmaceutical Compan rank is 546
Negative Cash Growth
La Jolla Pharmaceutical Compan rank is 599
High Put/Call
La Jolla Pharmaceutical Compan has a high Put/Call ratio of 1.03 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, La Jolla Pharmaceutical Compan is ranked 662.
High vPut/Call
La Jolla Pharmaceutical Compan has a high Put/Call ratio of 1.45 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, La Jolla Pharmaceutical Compan is ranked 806.
Down EPS Surprise
La Jolla Pharmaceutical Compan missed the consensus earnings estimate when it last reported quarterly earnings.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.